Simone Fulda
Simone Fulda (born March 15, 1968 in Cologne ) is a German child oncologist and professor at the Johann Wolfgang Goethe University in Frankfurt am Main .
Career
Fulda studied human medicine from 1988 to 1995 at the University of Cologne , at the Harvard Medical School in Boston (USA), at the University of California San Francisco (USA), at the University of Arizona in Phoenix (USA) and at the University College Dublin (Ireland). She received her doctorate in 1995 from the University of Cologne.
From 1995 to 2001 she completed her specialist training at the University Children's Clinics in Heidelberg and Ulm , as well as a postdoc at the German Cancer Research Center in Heidelberg and at the Gustave Roussy Institute in Villejuif (France), completing this as a specialist in paediatrics in 2001. In the same year , she completed her habilitation at the University of Ulm , where she carried out research from 2002 to 2007 as a Heisenberg fellow of the German Research Foundation , before taking up a DFG research professorship (W3) in pediatric research at the University of Ulm in 2007. In 2010 she was appointed Professor (W3) for Experimental Tumor Research and Director of the Institute for Experimental Tumor Research in Pediatrics at the Goethe University in Frankfurt am Main . Since 2018 she has been Vice President for Research and Academic Infrastructure at the Goethe University Frankfurt am Main. On June 24, 2020 she was elected President of the Christian Albrechts University in Kiel .
research
Fulda is a specialist in pediatric and adolescent medicine with a focus on oncology . She is investigating which molecular mechanisms play a role in childhood cancers and how these mechanisms prevent programmed cell death ( apoptosis ), which normally causes cells with damaged or altered genetic material to die. Fulda is also concerned with how these mechanisms can be used as targets for chemotherapeutic agents . She was able to show that tumor cells can be made accessible again for apoptosis through certain caspases (SMAC, second mitochondria-derived activator of caspases). Her research led to the pharmaceutical development of SMAC agonists. She was also able to show that betulinic acid can trigger apoptosis in certain tumor cells.
Awards
- since 2018 member of the National Academy of Sciences Leopoldina
- 2016 Ingrid zu Solms Foundation Special Prize / Research Prize of the Bern Foundation
- 2014 German Cancer Prize
- 2007 Johann Georg Zimmermann Research Prize
- 2006 Merckle Research Prize
- 2005 Walter Schulz Research Prize
- 2002 Vincenz-Czerny-Prize of the German Society for Hematology and Oncology
- 2002 Kind-Philipp-Prize of the Society for Pediatric Oncology and Hematology
- 2002 Schweisguth Prize from the International Society for Pediatric Oncology
- 2002–2007 Heisenberg grant from the German Research Foundation
- 2001 Ingrid zu Solms Science Prize from the State Medical Association of Hesse
- 1998 Award of the Society for Pediatric Oncology and Hematology
Web links
- Simone Fulda at Google Scholar
- Simone Fulda on the website of the Johann Wolfgang Goethe University Frankfurt am Main
Individual evidence
| personal data | |
|---|---|
| SURNAME | Fulda, Simone |
| BRIEF DESCRIPTION | German child oncologist and university professor |
| DATE OF BIRTH | March 15, 1968 |
| PLACE OF BIRTH | Cologne |